Sign In
Buy CVAC
$4.66
+0 (+0%)
At Close: Apr 02, 2026
Vaccine Contender CureVac Raises $213 Million in IPO
10:31am, Friday, 14'th Aug 2020
(Bloomberg) -- CureVac BV, a competitor in the race for a coronavirus vaccine, priced its U.S. initial public offering at the top of a marketed range to raise $213 million.The company sold 13.33 milli
